Macarius M. Donneyong

Dr. Macarius M. Donneyong

College of Public Health, The Ohio State University, Columbus, OH 43210, USA
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
TCTeng‐Jen Chang
Teng‐Jen Chang
JBJohn F. P. Bridges
John F. P. Bridges
MBMary Bynum
Mary Bynum
JJJohn W. Jackson
John W. Jackson
JJJoshua J. Joseph
Joshua J. Joseph
Macarius M. DonneyongMacarius M. Donneyong
Macarius M. Donneyong
Background: We assessed the associations between patient‐clinician relationships (communication and involvement in shared decision‐making [SDM]) and adherence to antihypertensive medications. Methods and Results: The 2010 to 2017 Medical Expenditure Panel Survey (MEPS) data were analyzed. A retrospective cohort study design was used to create a cohort of prevalent and new users of antihypertensive medications. We defined constructs of patient‐clinician communication and involvement in SDM from patient responses to the standard questionnaires about satisfaction and access to care during the first year of surveys. Verified self‐reported medication refill information collected during the second year of surveys was used to calculate medication refill adherence; adherence was defined as medication refill adherence ≥80%. Survey‐weighted multivariable‐adjusted logistic regression models were used to measure the odds ratio (OR) and 95% CI for the association between both patient‐clinician constructs and adherence. Our analysis involved 2571 Black adult patients with hypertension (mean age of 58 years; SD, 14 years) who were either persistent (n=1788) or new users (n=783) of antihypertensive medications. Forty‐five percent (n=1145) and 43% (n=1016) of the sample reported having high levels of communication and involvement in SDM, respectively. High, versus low, patient‐clinician communication (OR, 1.38; 95% CI, 1.14–1.67) and involvement in SDM (OR, 1.32; 95% CI, 1.08–1.61) were both associated with adherence to antihypertensives after adjusting for multiple covariates. These associations persisted among a subgroup of new users of antihypertensive medications. Conclusions: Patient‐clinician communication and involvement in SDM are important predictors of optimal adherence to antihypertensive medication and should be targeted for improving adherence among Black adults with hypertension.

16 November 2016 in The American Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
KBKatsiaryna Bykov
Katsiaryna Bykov
SSSebastian Schneeweiss
Sebastian Schneeweiss
Macarius M. DonneyongMacarius M. Donneyong
Macarius M. Donneyong
YDYaa-Hui Dong
Yaa-Hui Dong
NCNiteesh K. Choudhry
Niteesh K. Choudhry
JGJoshua J. Gagne
Joshua J. Gagne

29 November 2023 in Drug Safety
Verified
Journal Article
Closed access
PDF file
HDHarriet Dickinson
Harriet Dickinson
DTDana Y. Teltsch
Dana Y. Teltsch
JFJan Feifel
Jan Feifel
PHPhillip Reed Hunt
Phillip Reed Hunt
EVEnriqueta Vallejo-Yagüe
Enriqueta Vallejo-Yagüe
TGthe Actionable AI group
the Actionable AI group


Macarius M. DonneyongMacarius M. Donneyong
Macarius M. Donneyong
TCTeng-Jen Chang
Teng-Jen Chang
JJJohn W. Jackson
John W. Jackson
MLMichael Langston
Michael Langston
PJPaul Juarez
Paul Juarez
Darryl HoodDarryl Hood
Darryl Hood
Background: Non-adherence to antihypertensive medication treatment (AHM) is a complex health behavior with determinants that extend beyond the individual patient. The structural and social determinants of health (SDH) that predispose populations to ill health and unhealthy behaviors could be potential barriers to long-term adherence to AHM. However, the role of SDH in AHM non-adherence has been understudied. Therefore, we aimed to define and identify the SDH factors associated with non-adherence to AHM and to quantify the variation in county-level non-adherence to AHM explained by these factors. Methods: Two cross-sectional datasets, the Centers for Disease Control and Prevention (CDC) Atlas of Heart Disease and Stroke (2014–2016 cycle) and the 2016 County Health Rankings (CHR), were linked to create an analytic dataset. Contextual SDH variables were extracted from the CDC-CHR linked dataset. County-level prevalence of AHM non-adherence, based on Medicare fee-for-service beneficiaries’ claims data, was extracted from the CDC Atlas dataset. The CDC measured AHM non-adherence as the proportion of days covered (PDC) with AHM during a 365 day period for Medicare Part D beneficiaries and aggregated these measures at the county level. We applied confirmatory factor analysis (CFA) to identify the constructs of social determinants of AHM non-adherence. AHM non-adherence variation and its social determinants were measured with structural equation models. Results: Among 3000 counties in the U.S., the weighted mean prevalence of AHM non-adherence (PDC < 80%) in 2015 was 25.0%, with a standard deviation (SD) of 18.8%. AHM non-adherence was directly associated with poverty/food insecurity (β = 0.31, P-value < 0.001) and weak social supports (β = 0.27, P-value < 0.001), but inversely with healthy built environment (β = −0.10, P-value = 0.02). These three constructs explained one-third (R2 = 30.0%) of the variation in county-level AHM non-adherence. Conclusion: AHM non-adherence varies by geographical location, one-third of which is explained by contextual SDH factors including poverty/food insecurity, weak social supports and healthy built environments.

5 January 2018 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
MSMichael S Sinha
Michael S Sinha
CFClark C Freifeld
Clark C Freifeld
JBJohn S. Brownstein
John S. Brownstein
Macarius M. DonneyongMacarius M. Donneyong
Macarius M. Donneyong
PRPaula Rausch
Paula Rausch
AKAaron S Kesselheim
Aaron S Kesselheim
A multidisciplinary journal that focuses on public health and technology, public health informatics, mass media campaigns, surveillance, and innovation in public health practice and research. Also dedicated to rapid open data sharing during epidemics.